Filing Flows › Yarrow Bioscience (YARW) › Q2 2026
Yarrow Bioscience (YARW) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 13, 2026
Yarrow Bioscience (YARW) reported revenue of $97K for the second quarter 2026 (Q2 2026), +41% from a year earlier and +13% from the quarter before.
Yarrow Bioscience, Q2 2026: revenue $97K (+41% year over year), net loss $3.0M, operating cash flow −$2.0M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $97K | +13% | +41% |
| Operating profit | −$3.1M | — | — |
| Net earnings | −$3.0M | — | — |
| Operating cash flow | −$2.0M | — | — |
What changed
Revenue was $97K in Q2 2026, up 41% year over year and up 13% from the previous quarter.
Operating costs exceeded revenue by $3.1M, an operating margin of -3197.9%. Total costs fell 58% while revenue rose 41%. The quarter ended with a net loss of $3.0M, narrower than the previous quarter's $3.6M loss.
Operating cash flow was −$2.0M. Non-cash charges added back $6K of depreciation and amortization and $436K of share-based compensation. Working capital and other items added $573K.
Questions
What was Yarrow Bioscience's revenue in the second quarter 2026?
Yarrow Bioscience (YARW) reported revenue of $97K for the second quarter 2026 (Q2 2026), +41% from a year earlier and +13% from the quarter before.
Source: Yarrow Bioscience 10-Q on SEC EDGAR.